Release Date: 2023-09-14

Management and Postpartum Follow-Up of Gestational Diabetes

Aliye Nigar Serin (Author), Gamze Savci (Author)

Release Date: 2023-09-14

Gestational diabetes mellitus (GDM) requires effective management during pregnancy and careful postpartum follow-up. Initially managed through dietary adjustments and exercise, some cases may require insulin therapy to maintain blood glucose levels within normal ranges. Postpartum, women diagnosed with GDM should undergo glucose testing at 6-12 weeks after delivery to screen for persistent diabetes. Lifestyle modifications, [...]

Media Type
  • PDF

Buy from

Price may vary by retailers

Work TypeBook Chapter
Published inCurrent Perspective on Diabetes Mellitus in Clinical Sciences
First Page279
Last Page286
DOIhttps://doi.org/10.69860/nobel.9786053359111.26
ISBN978-605-335-911-1 (PDF)
LanguageENG
Page Count8
Copyright HolderNobel Tıp Kitabevleri
Licensehttps://nobelpub.com/publish-with-us/copyright-and-licensing
Gestational diabetes mellitus (GDM) requires effective management during pregnancy and careful postpartum follow-up. Initially managed through dietary adjustments and exercise, some cases may require insulin therapy to maintain blood glucose levels within normal ranges. Postpartum, women diagnosed with GDM should undergo glucose testing at 6-12 weeks after delivery to screen for persistent diabetes. Lifestyle modifications, including regular physical activity and healthy eating, remain essential to prevent the development of type 2 diabetes in the future. Monitoring and support from healthcare providers are critical to ensure optimal maternal health and reduce the risk of complications in subsequent pregnancies.
  • E. Anastasiou, G. Farmakidis, A. Gerede, D.G. Goulis, E. Koukkou, A. Kourtis et al. Clinical practice guidelines on diabetes mellitus and pregnancy: Ι. Pre-existing type 1 type 2 diabetes Mellit. Hormones, 2020, 19, 593–600.

  • Diabetes in Pregnancy: Management from preconception to the postnatal period. NICE Guideline, 2015.

  • Dabelea D, Hanson RL, Lindsay RS, et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes 2000;49:2208–2211

  • Holmes VA, Young IS, Patterson CC, et al.; Diabetes and Pre-eclampsia Intervention Trial Study Group. Optimal glycemic control, preeclampsia, and gestational hypertension in women with type 1 diabetes in the Diabetes and Pre-eclampsia Intervention Trial. Diabetes Care 2011;34:1683–1688

  • ACOG Committee Opinion No. 762: Prepregnancy Counseling. Obstet Gynecol 2019;133: e78–e89

  • Management of diabetes in pregnancy: Standards of medical care in diabetes – 2019, American Diabetes Association, Diabetes Care 2019; 42 (supplement 1): S165-S172

  • Wald NJ, Law MR, Morris JK, Wald DS. Quantifying the effect of folic acid. Lancet 2001; 358(9298): 2069–2073.

  • Committee on Practice B-O. Practice bulletin no. 187: neural tube defects. Obstet Gynecol. 2017; 130(6): e279–e290.

  • Öztürk FY, Altuntaş Y. Gestasyonel diabetes mellitus. Şişli Etfal Hastanesi Tıp Bülteni 2015;49:1-10.

  • Parrettini S., Caroli A., Torlone E. Nutrition and Metabolic Adaptations in Physiological and Complicated Pregnancy: Focus on Obesity and Gestational Diabetes. Front Endocrinol. (Lausanne). 11, (2020).

  • Widyaputri F, Rogers SL, Kandasamy R, Shub A, Symons RCA, Lim LL. Global estimates of diabetic retinopathy prevalence and progression in pregnant women with preexisting diabetes: a systematic review and meta-analysis. JAMA Ophthalmol 2022;140:486–494

  • Bayram M. et all. Perinatoloji Uzmanları Derneği Gebelik Ve Diyabet Kılavuzu (2019).

  • Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2023, American Diabetes Association Professional Practice Committee (2023). Diabetes Care 2023;46 (Suppl. 1):S254–S266.

  • ACOG Committee Opinion No. 743: Low-dose aspirin use during pregnancy. Obstet Gynecol 2018; 132: e44–e52.

  • Hadden DR. The management of diabetes in pregnancy. Postgrad Med J 1996; 72:525–31.

  • Cunningham FG, Leveno KJ, Bloom SL, et al. Diabetes Mellitus. In: Cunningham FG, Leveno KJ, Bloom SL, et al., Eds, Williams Obstetrics, 25th Ed., McGraw Hill, USA, 2018; p:1097-1117.

  • Garner PR. Type I diabetes and pregnancy. Lancet 1995; 346:157-161.

  • Durnwald C. Gestational diabetes mellitus: Glucose management and maternal prognosis. Update 2023.

  • Hartling L, Dryden DM, Guthrie A, et al. Benefi ts and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the U.S. Preventive Services Task Force and the National Institutes of Health Offi ce of Medical Applications of Research. Ann Intern Med 2013; 159:123.

  • Landon MB, Spong CY, Thom E, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009; 361:1339.

  • The Art and Science of Diabetes Self-Management Education, Mensing C (Ed), American Association of Diabetes Educators, 2006. p.241.

  • ACOG Committee Opinion. No 700 Methods for Estimating the Due Date (May 2017). Obstet Gynecol 2017; 129:e150-e154.

  • ACOG Bulletins-Obstetrics Practice bulletin no. 173. Fetal macrosomia. Obstet Gynecol 2016; 128(5): e195–e209

  • Stutchfi eld PWR, Russell I. Antenatal betamethasone and incidence of neonatal respiratory distress after elective cesarean section: a pragmatic randomized trial. BMJ. 2005; 331: 662.

  • ACOG Practice Bulletin No: 60 Pregestational diabetes mellitus. Obstet Gynecol 2005;105:675-685.

Share This Chapter!